Rayner CK, Wu T, Aroda VR, Whittington C, et al. Gastrointestinal adverse events with insulin glargine/lixisenatide fixed-ratio combination versus GLP-1 RAs in people with type 2 diabetes mellitus: a network meta-analysis. Diabetes Obes Metab 2020 Sep 29. doi: 10.1111/dom.14202.
PMID: 32991041